aluates Reports

$ 0.0

Automative

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-5Q2346

Global Non steroidal Anti inflammatory Drugs NSAID Market Insights and Forecast to 2028

BUY CHAPTERS

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report 2025

Code: QYRE-Auto-5Q2346

Report

September 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Ecotrin

GENERIC

St. Joseph

Elanco

Zoetis Inc

Boehringer Ingelheim

Merial

Merck Animal Health

Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Non-steroidal Anti-inflammatory Drugs (NSAID) Market

The global market for Non-steroidal Anti-inflammatory Drugs (NSAID) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-steroidal Anti-inflammatory Drugs (NSAID), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-steroidal Anti-inflammatory Drugs (NSAID).

The Non-steroidal Anti-inflammatory Drugs (NSAID) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-steroidal Anti-inflammatory Drugs (NSAID) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-steroidal Anti-inflammatory Drugs (NSAID) Market Report

Report Metric	Details
Report Name	Non-steroidal Anti-inflammatory Drugs (NSAID) Market
CAGR	5%
Segment by Type	Salicylates Propionic acid derivatives Acetic acid derivatives Enolic acid (Oxicam) derivatives Anthranilic acid derivatives (Fenamates) Selective COX-2 inhibitors (Coxibs) Sulfonanilides
Segment by Application	Human Animals Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial, Merck Animal Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-steroidal Anti-inflammatory Drugs (NSAID) Market report?

Ans: The main players in the Non-steroidal Anti-inflammatory Drugs (NSAID) Market are Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial, Merck Animal Health

What are the Application segmentation covered in the Non-steroidal Anti-inflammatory Drugs (NSAID) Market report?

Ans: The Applications covered in the Non-steroidal Anti-inflammatory Drugs (NSAID) Market report are Human, Animals, Others

What are the Type segmentation covered in the Non-steroidal Anti-inflammatory Drugs (NSAID) Market report?

Ans: The Types covered in the Non-steroidal Anti-inflammatory Drugs (NSAID) Market report are Salicylates, Propionic acid derivatives, Acetic acid derivatives, Enolic acid (Oxicam) derivatives, Anthranilic acid derivatives (Fenamates), Selective COX-2 inhibitors (Coxibs), Sulfonanilides

1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview

1.1 Product Definition

1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) by Type

1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Salicylates

1.2.3 Propionic acid derivatives

1.2.4 Acetic acid derivatives

1.2.5 Enolic acid (Oxicam) derivatives

1.2.6 Anthranilic acid derivatives (Fenamates)

1.2.7 Selective COX-2 inhibitors (Coxibs)

1.2.8 Sulfonanilides

1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) by Application

1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value by Application (2024 VS 2031)

1.3.2 Human

1.3.3 Animals

1.3.4 Others

1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Estimates and Forecasts

1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2020-2031

1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2020-2031

1.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers

2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Product Type & Application

2.7 Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Date of Enter into This Industry

2.8 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends

2.8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players Market Share by Revenue

2.8.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Scenario by Region

3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2020-2031

3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2020-2025

3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2026-2031

3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2020-2031

3.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2020-2025

3.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2026-2031

3.4 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country

3.4.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2031)

3.4.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country

3.5.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2031)

3.5.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Region

3.6.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2020-2031)

3.6.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country

3.7.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2031)

3.7.3 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country

3.8.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2020-2031)

4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2020-2025)

4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2026-2031)

4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2020-2031)

4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2020-2031)

4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2020-2025)

4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2026-2031)

4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2020-2031)

4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2020-2031)

5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2020-2025)

5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2026-2031)

5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2020-2031)

5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2020-2031)

5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2020-2025)

5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2026-2031)

5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2020-2031)

5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Company Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Ecotrin

6.2.1 Ecotrin Company Information

6.2.2 Ecotrin Description and Business Overview

6.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.2.5 Ecotrin Recent Developments/Updates

6.3 Generic

6.3.1 Generic Company Information

6.3.2 Generic Description and Business Overview

6.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.3.5 Generic Recent Developments/Updates

6.4 St. Joseph

6.4.1 St. Joseph Company Information

6.4.2 St. Joseph Description and Business Overview

6.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.4.5 St. Joseph Recent Developments/Updates

6.5 Elanco

6.5.1 Elanco Company Information

6.5.2 Elanco Description and Business Overview

6.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.5.5 Elanco Recent Developments/Updates

6.6 Zoetis

6.6.1 Zoetis Company Information

6.6.2 Zoetis Description and Business Overview

6.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.6.5 Zoetis Recent Developments/Updates

6.7 Boehringer Ingelheim

6.7.1 Boehringer Ingelheim Company Information

6.7.2 Boehringer Ingelheim Description and Business Overview

6.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.7.5 Boehringer Ingelheim Recent Developments/Updates

6.8 Merial

6.8.1 Merial Company Information

6.8.2 Merial Description and Business Overview

6.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.8.5 Merial Recent Developments/Updates

6.9 Merck Animal Health

6.9.1 Merck Animal Health Company Information

6.9.2 Merck Animal Health Description and Business Overview

6.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio

6.9.5 Merck Animal Health Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Analysis

7.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process Analysis

7.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Marketing

7.4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels

7.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors

7.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Customer Analysis

8 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Dynamics

8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends

8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers

8.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges

8.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bayer

Ecotrin

GENERIC

St. Joseph

Elanco

Zoetis Inc

Boehringer Ingelheim

Merial

Merck Animal Health

List of Tables

Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Product Type & Application

Table 12. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2020-2025) & (K Units)

Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2020-2025)

Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2026-2031) & (K Units)

Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2026-2031)

Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2020-2025)

Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2026-2031)

Table 25. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025) & (K Units)

Table 27. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2026-2031) & (K Units)

Table 28. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2020-2025)

Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2026-2031)

Table 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2020-2025)

Table 53. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2026-2031)

Table 54. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2020-2025)

Table 57. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2026-2031)

Table 58. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2020-2025)

Table 59. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2026-2031)

Table 60. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2020-2025)

Table 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2026-2031)

Table 62. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2020-2025)

Table 63. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2026-2031)

Table 64. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2020-2025)

Table 67. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2026-2031)

Table 68. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2020-2025)

Table 69. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2026-2031)

Table 70. Bayer Company Information

Table 71. Bayer Description and Business Overview

Table 72. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 74. Bayer Recent Developments/Updates

Table 75. Ecotrin Company Information

Table 76. Ecotrin Description and Business Overview

Table 77. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 79. Ecotrin Recent Developments/Updates

Table 80. Generic Company Information

Table 81. Generic Description and Business Overview

Table 82. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 84. Generic Recent Developments/Updates

Table 85. St. Joseph Company Information

Table 86. St. Joseph Description and Business Overview

Table 87. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 89. St. Joseph Recent Developments/Updates

Table 90. Elanco Company Information

Table 91. Elanco Description and Business Overview

Table 92. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 94. Elanco Recent Developments/Updates

Table 95. Zoetis Company Information

Table 96. Zoetis Description and Business Overview

Table 97. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 99. Zoetis Recent Developments/Updates

Table 100. Boehringer Ingelheim Company Information

Table 101. Boehringer Ingelheim Description and Business Overview

Table 102. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 104. Boehringer Ingelheim Recent Developments/Updates

Table 105. Merial Company Information

Table 106. Merial Description and Business Overview

Table 107. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 109. Merial Recent Developments/Updates

Table 110. Merck Animal Health Company Information

Table 111. Merck Animal Health Description and Business Overview

Table 112. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product

Table 114. Merck Animal Health Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List

Table 118. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List

Table 119. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends

Table 120. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers

Table 121. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges

Table 122. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)

Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type: 2024 & 2031

Figure 4. Salicylates Product Picture

Figure 5. Propionic acid derivatives Product Picture

Figure 6. Acetic acid derivatives Product Picture

Figure 7. Enolic acid (Oxicam) derivatives Product Picture

Figure 8. Anthranilic acid derivatives (Fenamates) Product Picture

Figure 9. Selective COX-2 inhibitors (Coxibs) Product Picture

Figure 10. Sulfonanilides Product Picture

Figure 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value by Application (2020-2031) & (US$ Million)

Figure 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application: 2024 & 2031

Figure 13. Human

Figure 14. Animals

Figure 15. Others

Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (2020-2031) & (US$ Million)

Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2020-2031) & (K Units)

Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) & (2020-2031)

Figure 20. Non-steroidal Anti-inflammatory Drugs (NSAID) Report Years Considered

Figure 21. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers in 2024

Figure 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players: Market Share by Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) in 2024

Figure 24. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2020-2031)

Figure 27. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2020-2031)

Figure 28. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2020-2031)

Figure 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2020-2031)

Figure 32. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2020-2031)

Figure 39. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Philippines Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2020-2031)

Figure 50. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2020-2031)

Figure 51. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2020-2031)

Figure 56. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2020-2031)

Figure 60. Global Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2020-2031)

Figure 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2020-2031)

Figure 62. Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2020-2031)

Figure 63. Global Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2020-2031)

Figure 64. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2020-2031)

Figure 65. Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global NSAIDs Market Research Report 2025

Global Non Steroidal Anti Inflammatory API Market Research Report 2025

Non opioid Topical Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non opioid Pain Med Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Corticosteroid Anti inflammatory Eyedrops Market Insights Forecast to 2030

Non Insulin Therapies for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antipyretic and Analgesic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non infectious Uveitis Treatment Market Research Report 2025

OTC Oral Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global OTC Pain Medicines Market Research Report 2024

Over the Counter OTC Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Invasive Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inflammatory Bowel Disease IBD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions